Viewing Study NCT00001133


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-26 @ 1:23 AM
Study NCT ID: NCT00001133
Status: COMPLETED
Last Update Posted: 2021-11-01
First Post: 2000-01-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module